7 Results for "

MERS-CoV main protease

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "MERS-CoV main protease" in MCE Product Catalog:

Cat. No.: HY-178188
Target:  

SARS-CoV

Research Areas:  

Infection

TPG-20A is a SARS-CoV-2 main protease inhibitor with an IC50 of 27.8 nM. TPG-20A also inhibits MERS-CoV main protease. TPG-20A can be used for the research of infection, such as SARS-CoV-2 .
loading...
    loading...
Cat. No.: HY-183956
CAS No.: 2170616-59-6
Target:  

SARS-CoV

Research Areas:  

Infection

GC813 is a MERS-CoV 3CL protease (3CLpro) and MERS-CoV main protease (Mpro) inhibitor. GC813 can be used for the research of middle east respiratory syndrome .
loading...
    loading...
Cat. No.: HY-121020
CAS No.: 83162-82-7
Arcapillin is a flavonoid that can be isolated from Artemisia capillaris Thunb. Arcapillin induces dose-dependent relaxation of ileum and pulmonary artery smooth muscle, causes slight urinary bladder smooth muscle contraction at highest tested concentrations. Arcapillin binds to the active site of SARS-CoV-2 Mpro via interactions with Gln139, His163, and His164, exhibits antiviral activity against SARS-CoV-2 and MERS-CoV. Arcapillin can be used for the research of gastrointestinal disorders, COVID-19, and Middle East respiratory syndrome (MERS) .
loading...
    loading...
Cat. No.: HY-151990
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2/MERS Mpro-IN-1 (compound 9c) is a potent SARS-CoV-2 and MERS main protease inhibitor with IC50 values of 0.10, 0.06 µM, respectively .
loading...
    loading...
Cat. No.: HY-151991
CAS No.: 3034217-02-9
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2/MERS Mpro-IN-2 (compound 9d) is a potent SARS-CoV-2 and MERS main protease inhibitor with IC50 values of 0.21, 0.07 µM, respectively .
loading...
    loading...
Cat. No.: HY-187507
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

AVI8122 is a covalent coronavirus main protease (M pro) inhibitor, with IC50 values of 0.0047 μM, 0.065 μM, 0.04 μM, 0.004 μM, 0.027 μM and 0.020 μM against SARS-CoV-2, MERS-CoV, HKU8, PEDV, IBV and HKU15, respectively; it exhibits Ki values of 0.14 nM, 1.8 nM, 0.9 nM, 0.2 nM and 5.2 nM against SARS-CoV-2, HKU8, PEDV, IBV and HKU15, respectively. AVI8122 forms a covalent hemithioacetal bond with the catalytic cysteine of M pro, blocks its proteolytic activity, and acts on the four coronavirus genera α, β, γ and δ. AVI8122 is applicable to research related to SARS-CoV-2 infection .\n
loading...
    loading...
Cat. No.: HY-170894
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 Mpro-IN-37 (compound 8r) is a SARS-CoV-2 main protease (M pro) inhibitor, with an IC50 of 0.0199 μM. SARS-CoV-2 Mpro-IN-37 inhibits SARS-CoV-1 M pro and MERS-CoV M pro with IC50s of 0.00945 and 0.111 μM, respectively. SARS-CoV-2 Mpro-IN-37 displays high antiviral activity in the nanomolar range without showing cellular toxicity .
loading...
    loading...